
Myelodysplastic Syndromes
MDS
📋Overview
Myelodysplastic syndromes (MDS) are a group of diverse bone marrow disorders characterized by ineffective blood cell production and abnormal development of blood cells. MDS is considered a clonal hematopoietic stem cell disorder that can progress to acute myeloid leukemia (AML) in some cases. The term 'myelodysplastic syndromes' is the modern preferred terminology, replacing older terms such as 'preleukemia' or 'smoldering leukemia.'
Medical codes (for reference)
UMLS CUI: C3463824ICD-10-CM
D46D46.9
MeSH
D009190
SNOMED CT (US)
128623006109995007
Codes are provided for reference and interoperability. They are not a diagnosis.
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.